Page last updated: 2024-08-24

ranolazine and atenolol

ranolazine has been researched along with atenolol in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Akahane, M; Endo, T; Komatsu, H; Maruyama, K; Murakami, M; Wang, JX1
Chaitman, BR; Chumakova, G; Kuch, J; Parker, JO; Pepine, CJ; Skettino, SL; Skopal, J; Wang, W; Wolff, AA1
Gratsianskiĭ, NA1
Cocco, G; Pouleur, H; Rousseau, MF; Wolff, AA1

Reviews

1 review(s) available for ranolazine and atenolol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

2 trial(s) available for ranolazine and atenolol

ArticleYear
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    JAMA, 2004, Jan-21, Volume: 291, Issue:3

    Topics: Acetanilides; Adrenergic beta-Antagonists; Aged; Amlodipine; Angina Pectoris; Atenolol; Calcium Channel Blockers; Cardiovascular Agents; Chronic Disease; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Physical Exertion; Piperazines; Ranolazine; Survival Analysis

2004
Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
    The American journal of cardiology, 2005, Feb-01, Volume: 95, Issue:3

    Topics: Acetanilides; Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Angina Pectoris; Atenolol; Blood Pressure; Chronic Disease; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Exercise Test; Female; Heart Rate; Humans; Linear Models; Male; Middle Aged; Myocardial Ischemia; Piperazines; Ranolazine; Treatment Outcome

2005

Other Studies

3 other study(ies) available for ranolazine and atenolol

ArticleYear
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Antianginal effects of ranolazine in various experimental models of angina.
    Arzneimittel-Forschung, 1999, Volume: 49, Issue:3

    Topics: Acetanilides; Administration, Oral; Adrenergic beta-Antagonists; Anesthesia; Angina Pectoris; Animals; Atenolol; Dogs; Duodenum; Electrocardiography; Epinephrine; Female; Intubation, Gastrointestinal; Male; Myocardial Ischemia; Piperazines; Ranolazine; Rats; Rats, Wistar; Vasoconstrictor Agents; Vasopressins

1999
[Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina. Results of CARISA].
    Kardiologiia, 2004, Volume: 44, Issue:3

    Topics: Acetanilides; Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Atenolol; Cardiovascular Agents; Chronic Disease; Diltiazem; Double-Blind Method; Exercise Test; Humans; Multicenter Studies as Topic; Piperazines; Placebos; Randomized Controlled Trials as Topic; Ranolazine; Time Factors; Vasodilator Agents

2004